1
Return

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease

delete2013-06-21
delete349
delete
OA
AI
S
Sruti Rayaprolu
B
Bianca Mullen
M
Matt Baker
T
Timothy Lynch
E
Elizabeth Finger
W
William W. Seeley
K
Kimmo J. Hatanpaa
C
Catherine Lomen‐Hoerth
A
Andrew Kertesz
E
Eileen H. Bigio
C
Carol F. Lippa
K
Keith A. Josephs
D
David S. Knopman
C
Charles L. White
R
Richard J. Caselli
I
Ian R. Mackenzie
B
Bruce L. Miller
M
Magdalena Boczarska‐Jedynak
G
Grzegorz Opala
A
Anna Krygowska‐Wajs
M
Maria Barcikowska
S
Steven G. Younkin
R
Ronald Petersen
N
Nilüfer Ertekin‐Taner
R
Ryan J. Uitti
J
James F. Meschia
B
Boylan, Kevin B.
B
Bradley F. Boeve
N
Neill R. Graff‐Radford
Z
Zbigniew K. Wszołek
D
Dennis W. Dickson
R
Rosa Rademakers *
O
Owen A. Ross
DOI:10.1186/1750-1326-8-19delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Background: A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) gene has been reported to be a genetic risk factor for Alzheimer's disease by two independent groups (Odds ratio between 2.9-4.5). Given the key role of TREM2 in the effective phagocytosis of apoptotic neuronal cells by microglia, we hypothesized that dysfunction of TREM2 may play a more generalized role in neurodegeneration. With this in mind we set out to assess the genetic association of the Alzheimer's disease-related risk variant in TREM2 (rs75932628, p.R47H) with other related neurodegenerative disorders. Results: The study included 609 patients with frontotemporal dementia, 765 with amyotrophic lateral sclerosis, 1493 with Parkinson's disease, 772 with progressive supranuclear palsy, 448 with ischemic stroke and 1957 controls subjects free of neurodegenerative disease. A significant association was observed for the TREM2 p.R47H substitution in susceptibility to frontotemporal dementia (OR = 5.06; p-value = 0.001) and Parkinson's disease (OR = 2.67; p-value = 0.026), while no evidence of association with risk of amyotrophic lateral sclerosis, progressive supranuclear palsy or ischemic stroke was observed. Conclusions: Our results suggest that the TREM2 p.R47H substitution is a risk factor for frontotemporal dementia and Parkinson's disease in addition to Alzheimer's disease. These findings suggest a more general role for TREM2 dysfunction in neurodegeneration, which could be related to its role in the immune response.
Keywords:
TREM2
Frontotemporal dementia
Parkinson disease
Genetic association
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Molecular Neurodegeneration cover
Molecular Neurodegeneration
IF:
17.5
Papers:
1.4K
Citations:
1.1W

Organization

D
Drexel University
Scholars:
1.3W
Papers: 1.1W
Citations: 2.2W
W
western university (university of western ontario)
Scholars:
2.9W
Papers: 2.7W
Citations: 32
M
Mater Misericordiae University Hospital
Scholars:
2.4K
Papers: 1.4K
Citations: 1.2K
F
Feinberg School of Medicine
Scholars:
1.8W
Papers: 1.5W
Citations: 34
M
mayo clinic
Scholars:
8.0W
Papers: 6.5W
Citations: 84
University of California System cover
University of California System
Scholars:
37.2W
Papers: 33.6W
Citations: 6.6K
U
university of texas system
Scholars:
18.3W
Papers: 15.5W
Citations: 210
U
university of texas southwestern medical center dallas
Scholars:
1.8W
Papers: 1.4W
Citations: 28
U
university college dublin
Scholars:
2.5W
Papers: 2.2W
Citations: 22
N
Northwestern University
Scholars:
6.1W
Papers: 5.2W
Citations: 3.9K
Cited Papers

Cited Papers

Citing Papers

Citing Papers